Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
961 | 2936 | 38.5 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
1157 | 2 | FIBRINOLYSIS//PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1 | 9477 |
961 | 1 | PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1//FIBRINOLYSIS | 2936 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PLASMINOGEN ACTIVATOR INHIBITOR 1 | authKW | 792422 | 10% | 26% | 290 |
2 | PAI 1 | authKW | 642458 | 9% | 25% | 250 |
3 | FIBRINOLYSIS | journal | 509751 | 6% | 28% | 178 |
4 | PLASMINOGEN ACTIVATOR INHIBITOR | authKW | 331109 | 5% | 24% | 135 |
5 | PHARMACEUT BIOL PHYTOPHARMACOL | address | 252143 | 2% | 51% | 48 |
6 | PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 | authKW | 232335 | 2% | 32% | 69 |
7 | 4G 5G POLYMORPHISM | authKW | 199376 | 1% | 91% | 21 |
8 | TISSUE TYPE PLASMINOGEN ACTIVATOR | authKW | 137798 | 3% | 14% | 94 |
9 | PAI 1 INHIBITOR | authKW | 125523 | 0% | 93% | 13 |
10 | THROMBOSIS AND HAEMOSTASIS | journal | 105558 | 11% | 3% | 318 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 59887 | 43% | 0% | 1276 |
2 | Peripheral Vascular Diseases | 38957 | 34% | 0% | 995 |
3 | Cardiac & Cardiovascular System | 1952 | 11% | 0% | 330 |
4 | Medicine, Research & Experimental | 761 | 7% | 0% | 209 |
5 | Endocrinology & Metabolism | 630 | 7% | 0% | 201 |
6 | Biochemistry & Molecular Biology | 594 | 16% | 0% | 472 |
7 | Medicine, General & Internal | 113 | 5% | 0% | 137 |
8 | Biophysics | 72 | 3% | 0% | 87 |
9 | Medical Laboratory Technology | 46 | 1% | 0% | 27 |
10 | Cell Biology | 41 | 4% | 0% | 122 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACEUT BIOL PHYTOPHARMACOL | 252143 | 2% | 51% | 48 |
2 | CELLULAR PROT SCI | 97043 | 0% | 67% | 14 |
3 | CLIN CHEM BLOOD COAGULAT | 56597 | 0% | 39% | 14 |
4 | EPI 9936 | 46790 | 0% | 75% | 6 |
5 | DEMOG STAT STUDIES | 27727 | 0% | 67% | 4 |
6 | HUMAN SERV MANAGEMENT PUBL ADM | 20797 | 0% | 100% | 2 |
7 | ISOTOPE PHARM | 20797 | 0% | 100% | 2 |
8 | SERV BIOCHIM HORMONAL | 20797 | 0% | 100% | 2 |
9 | CLIN EXPT | 18621 | 1% | 7% | 27 |
10 | CELLULAR PROTEIN SCI | 15595 | 0% | 50% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FIBRINOLYSIS | 509751 | 6% | 28% | 178 |
2 | THROMBOSIS AND HAEMOSTASIS | 105558 | 11% | 3% | 318 |
3 | FIBRINOLYSIS & PROTEOLYSIS | 101412 | 2% | 20% | 49 |
4 | THROMBOSIS RESEARCH | 53172 | 8% | 2% | 229 |
5 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 12979 | 3% | 1% | 97 |
6 | BLOOD COAGULATION & FIBRINOLYSIS | 12884 | 2% | 2% | 64 |
7 | ARTERIOSCLEROSIS AND THROMBOSIS | 4930 | 1% | 2% | 20 |
8 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 4622 | 1% | 1% | 42 |
9 | HAEMOSTASIS | 3672 | 1% | 2% | 21 |
10 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 3334 | 1% | 1% | 23 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VAN DE CRAEN, B , DECLERCK, PJ , GILS, A , (2012) THE BIOCHEMISTRY, PHYSIOLOGY AND PATHOLOGICAL ROLES OF PAI-1 AND THE REQUIREMENTS FOR PAI-1 INHIBITION IN VIVO.THROMBOSIS RESEARCH. VOL. 130. ISSUE 4. P. 576-585 | 129 | 81% | 31 |
2 | GILS, A , DECLERCK, PJ , (2004) PLASMINOGEN ACTIVATOR INHIBITOR-1.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 17. P. 2323-2334 | 145 | 76% | 36 |
3 | GILS, A , DECLERCK, PJ , (2004) THE STRUCTURAL BASIS FOR THE PATHOPHYSIOLOGICAL RELEVANCE OF PAL-L IN CARDIOVASCULAR DISEASES AND THE DEVELOPMENT OF POTENTIAL PAL-L INHIBITORS.THROMBOSIS AND HAEMOSTASIS. VOL. 91. ISSUE 3. P. 425-437 | 133 | 76% | 66 |
4 | DECLERCK, PJ , GILS, A , (2013) THREE DECADES OF RESEARCH ON PLASMINOGEN ACTIVATOR INHIBITOR-1: A MULTIFACETED SERPIN.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 39. ISSUE 4. P. 356-364 | 103 | 69% | 33 |
5 | HUBER, K , (2001) PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PART ONE): BASIC MECHANISMS, REGULATION, AND ROLE FOR THROMBOEMBOLIC DISEASE.JOURNAL OF THROMBOSIS AND THROMBOLYSIS. VOL. 11. ISSUE 3. P. 183 -193 | 118 | 71% | 52 |
6 | ROUCH, A , VANUCCI-BACQUE, C , BEDOS-BELVAL, F , BALTAS, M , (2015) SMALL MOLECULES INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1-AN OVERVIEW.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 92. ISSUE . P. 619 -636 | 64 | 79% | 9 |
7 | BARNARD, SA , PIETERS, M , DE LANGE, Z , (2016) THE CONTRIBUTION OF DIFFERENT ADIPOSE TISSUE DEPOTS TO PLASMA PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) LEVELS.BLOOD REVIEWS. VOL. 30. ISSUE 6. P. 421 -429 | 68 | 71% | 2 |
8 | DE TAEYE, B , GILS, A , DECLERCK, PJ , (2004) THE STORY OF THE SERPIN PLASMINOGEN ACTIVATOR INHIBITOR I: IS THERE ANY NEED FOR ANOTHER MUTANT?.THROMBOSIS AND HAEMOSTASIS. VOL. 92. ISSUE 5. P. 898-924 | 105 | 66% | 18 |
9 | KRISHNAMURTI, C , ALVING, BM , (1992) PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - BIOCHEMISTRY AND EVIDENCE FOR MODULATION OF FIBRINOLYSIS INVIVO.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 18. ISSUE 1. P. 67-80 | 120 | 81% | 60 |
10 | CESARI, M , PAHOR, M , INCALZI, RA , (2010) PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1): A KEY FACTOR LINKING FIBRINOLYSIS AND AGE-RELATED SUBCLINICAL AND CLINICAL CONDITIONS.CARDIOVASCULAR THERAPEUTICS. VOL. 28. ISSUE 5. P. E72 -E91 | 113 | 43% | 72 |
Classes with closest relation at Level 1 |